The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures
Background: From October 2018, adalimumab biosimilars could enter the European market.
However, in some countries, such as Netherlands, high discounts reported for the originator …
However, in some countries, such as Netherlands, high discounts reported for the originator …
Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?
B Godman, RE Malmström, E Diogene… - Expert review of …, 2015 - Taylor & Francis
Medicines have made an appreciable contribution to improving health. However, even high-
income countries are struggling to fund new premium-priced medicines. This will grow …
income countries are struggling to fund new premium-priced medicines. This will grow …
Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future …
B Godman, B Wettermark, M Van Woerkom… - Frontiers in …, 2014 - frontiersin.org
Introduction: The appreciable growth in pharmaceutical expenditure has resulted in multiple
initiatives across Europe to lower generic prices and enhance their utilization. However …
initiatives across Europe to lower generic prices and enhance their utilization. However …
Evidence-based public policy making for medicines across countries: findings and implications for the future
Aim: Global expenditure on medicines is rising up to 6% per year driven by increasing
prevalence of non-communicable diseases (NCDs) and new premium priced medicines for …
prevalence of non-communicable diseases (NCDs) and new premium priced medicines for …
Dabigatran–a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs
RE Malmström, BB Godman, E Diogene… - Frontiers in …, 2013 - frontiersin.org
Background: There are potential conflicts between authorities and companies to fund new
premium priced drugs especially where there are safety and/or budget concerns …
premium priced drugs especially where there are safety and/or budget concerns …
The prescribing of generic medicines in Nigeria: knowledge, perceptions and attitudes of physicians
Generic medicines have the same efficacy and safety as originators at lower prices;
however, there are concerns with their utilization in Nigeria. Objective was to evaluate …
however, there are concerns with their utilization in Nigeria. Objective was to evaluate …
Reforms and initiatives in Scotland in recent years to encourage the prescribing of generic drugs, their influence and implications for other countries
B Godman, I Bishop, AE Finlayson… - Expert review of …, 2013 - Taylor & Francis
Scotland has introduced a number of initiatives to enhance the prescribing of low-cost
generic drugs versus originators and patent products in a class where these are seen as …
generic drugs versus originators and patent products in a class where these are seen as …
The influence of a sustained multifaceted approach to improve antibiotic prescribing in Slovenia during the past decade: findings and implications
J Fürst, M Čižman, J Mrak, D Kos… - Expert review of anti …, 2015 - Taylor & Francis
Introduction: Rising antibiotic resistance has become an increasing public health problem.
There is a well-established correlation between antibiotic consumption and antimicrobial …
There is a well-established correlation between antibiotic consumption and antimicrobial …
Pricing of oral generic cancer medicines in 25 European countries; findings and implications
B Godman, A Hill, S Simoens, A Kurdi… - Generics and …, 2019 - pureportal.strath.ac.uk
Introduction: There are appreciable concerns among European health authorities with
growing expenditure on cancer medicines and issues of sustainability. The enhanced use of …
growing expenditure on cancer medicines and issues of sustainability. The enhanced use of …
Initiatives and reforms across Scotland in recent years to improve prescribing; findings and global implications of drug prescriptions
S MacBride-Stewart, S McTaggart… - … Journal of Clinical …, 2021 - pureportal.strath.ac.uk
Objective: Global expenditure on medicines is increasing driven by a number of factors.
These include the launch of new premium-priced medicines for complex diseases including …
These include the launch of new premium-priced medicines for complex diseases including …